NCT02808624View on ClinicalTrials.gov

L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Peripheral NeuropathyCancer
Interventions
DRUG

L-CARNOSINE

L-CARNOSINE is a supplement given with chemotherapy to prevent peripheral neuropathy.

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
collaborator

Misr International University

OTHER

collaborator

Ain Shams University

OTHER

lead

Cairo University

OTHER

NCT02808624 - L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients | Biotech Hunter | Biotech Hunter